Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Investigating Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers

NCT01273870 is registered in ClinicalTrials.gov with Praxisverbund Dialyse und Apherese as lead sponsor.

NCT NCT01273870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01273870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Investigating Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers
Lead sponsor
Praxisverbund Dialyse und Apherese
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
February 28, 2011
Enrollment
8 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal failure on dialysis